Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030884 |
---|---|
Receipt number | R000035262 |
Scientific Title | A comparison of remission rate at 8 weeks between combination therapy of Ustekinumab and Budesonide and monotherapy of Ustekinumab in moderate to severe Japanese Crohn's disease; A phase III, single-center, double blind, randomized control trial. |
Date of disclosure of the study information | 2018/02/20 |
Last modified on | 2019/07/23 11:08:29 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/01/18 20:57:37 | ||
2 | Update | 2018/02/19 08:34:50 | Public title |
|
3 | Update | 2018/02/19 09:13:31 | Primary outcomes Key secondary outcomes |
|
4 | Update | 2018/02/19 09:16:07 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Key exclusion criteria |
|
5 | Update | 2018/07/20 16:05:17 | Recruitment status |
|
6 | Update | 2019/07/23 11:06:43 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
7 | Update | 2019/07/23 11:08:29 | Date of IRB Last follow-up date |